Welcome to the world's leading Postgraduate Forum
An active and supportive community.
Support and advice from your peers.
Your postgraduate questions answered.
Use your experience to help others.
Hi fellow PhD students,
I am looking for the following article: PHASE II, OPEN-LABEL, RANDOMIZED STUDY (SIGN) OF SINGLE-AGENT GEFITINIB (IRESSA) OR DOCETAXEL AS SECOND-LINE THERAPY IN PATIENTS WITH ADVANCED (STAGE IIIB OR IV) NON-SMALL-CELL LUNG CANCER.
Anyone happens to have access? I will be very grateful!
Thank you in advance
PostgraduateForum Is a trading name of FindAUniversity Ltd
FindAUniversity Ltd, 77 Sidney St, Sheffield, S1 4RG, UK. Tel +44 (0) 114 268 4940 Fax: +44 (0) 114 268 5766
An active and supportive community.
Support and advice from your peers.
Your postgraduate questions answered.
Use your experience to help others.
Enter your email address below to get started with your forum account
Enter your username below to login to your account
An email has been sent to your email account along with instructions on how to reset your password. If you do not recieve your email, or have any futher problems accessing your account, then please contact our customer support.
or continue as guest
To ensure all features on our website work properly, your computer, tablet or mobile needs to accept cookies. Our cookies don’t store your personal information, but provide us with anonymous information about use of the website and help us recognise you so we can offer you services more relevant to you. For more information please read our privacy policy
Agree Agree